Dr. Gill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S Grant Ave
Ste 208
Columbus, OH 43215Phone+1 614-566-9143Fax+1 614-566-8080
Education & Training
University of Missouri-ColumbiaResidency, Internal Medicine, 2003 - 2006
Des Moines University College of Osteopathic MedicineClass of 2003
Certifications & Licensure
MI State License 2017 - 2027
VA State License 2024 - 2026
IN State License 2009 - 2025
KY State License 2018 - 2025
OH State License 2007 - 2025
WI State License 2024 - 2025- AOA Board of Internal Medicine Critical Care Medicine (CAQ)
- AOA Board of Internal Medicine Pulmonary Diseases
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Pain and Safety of Microneedles in Oral Cavity Start of enrollment: 2018 Jan 16
Publications & Presentations
PubMed
- 102 citationsCutaneous vaccination using microneedles coated with hepatitis C DNA vaccineHarvinder S. Gill, Jonas Söderholm, Mark R. Prausnitz, Matti Sällberg
Gene Therapy. 2010-03-04 - 91 citationsMicroneedle Coating Methods: A Review with a Perspective.Rohan S.J. Ingrole, Harvinder S. Gill
The Journal of Pharmacology and Experimental Therapeutics. 2019-09-01 - 387 citationsCoated microneedles for transdermal deliveryHarvinder S. Gill, Mark R. Prausnitz
Journal of Controlled Release. 2007-02-12
Press Mentions
- Review A Practical Guide to the Development of Microneedle Systems – in Clinical Trials or on the MarketOctober 31st, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
